Androxal

Basic Androxal Information

• INN (International Nonproprietary Name): Enclomifene
• Brand names available in United Kingdom: Not commercially available in UK pharmacies; Androxal® was intended as a brand name but has no licensed UK product
• ATC Code: No ATC code assigned
• Forms & dosages: Oral tablets in clinical studies only, usually 12.5 mg or 25 mg once daily
• Manufacturers in United Kingdom: None licensed in the UK
• Registration status in United Kingdom: No UK licence, no MHRA approval, no routine NHS use
• OTC / Rx classification: Prescription-only in investigational settings; not available over the counter

Everyday Use & Best Practices

Patients often ask a very practical question first: if enclomifene were ever prescribed, when would it be taken and does food matter?

For Androxal, the honest answer is that daily-use advice comes from clinical-trial information only, because it is not commercially available or licensed in the UK.

In studies, enclomifene was usually taken as an oral tablet once daily, often at 12.5 mg or 25 mg, and the usual approach in any specialist setting would be to keep to the same time each day.

That steady routine matters because it helps with adherence, and it is the kind of simple UK pharmacist advice patients already know from other clomifene tablets or hormone-related treatments.

Food did not appear to be a major issue in the available data, but real-world advice would still be to check the patient information leaflet if a specialist ever prescribed it.

A patient who takes medicines with breakfast, for example, would usually be advised to keep that pattern rather than changing it from morning to night without specialist advice.

If it were taken in the evening, the same principle would apply: pick a time that fits the day and stick to it.

What matters most is consistency rather than chasing an “ideal” moment that has never been established for routine NHS care.

Daily checklist:

• Take it at the same time each day.
• Do not self-adjust the dose.
• Store it safely and keep it in the original packaging.
• Ask a pharmacist before combining it with supplements or other hormone products.

If you are reading about enclomifene on forums, it is worth remembering that a once daily schedule in clinical studies does not make it a standard UK treatment.

Safety Priorities

Before anyone thinks about how a medicine works, the first question should always be whether it is suitable and safe.

Androxal has no MHRA approval, no UK licence, and no routine NHS use.

The main contraindications reported in the source data are hypersensitivity to enclomifene or clomifene compounds, hormone-dependent tumours such as breast, uterine, or prostate cancer, and pregnancy.

Caution is also advised in severe liver or kidney impairment, people with uncontrolled pituitary or ovarian disorders, and anyone with a history of thrombosis or embolism.

That safety picture is one reason a pharmacist would not treat it like an ordinary pharmacy purchase.

Common side effects include headache, nausea, visual disturbances such as blurred vision or spots, hot flushes, and mood changes.

Those effects are not just inconvenient; they can affect concentration, judgment, and safe working.

Red flags and when to seek help:

• New blurred vision, flashing spots, or any change in eyesight.
• Severe headache, faintness, or feeling unusually unwell.
• Chest pain, swelling, sudden shortness of breath, or other signs that could suggest a clot.
• Marked mood changes or nausea that make normal activity difficult.

In everyday UK terms, that means thinking carefully about driving, operating machinery, warehouse work, construction, and night shifts.

If visual symptoms appear, patients should speak to a pharmacist, GP, or NHS 111 promptly.

Any suspected adverse effect can also be reported through the MHRA Yellow Card scheme.

Dosage & Adjustments

There is no NHS dosing guidance for Androxal because it is experimental and not approved in the UK.

The available data come from clinical studies in male secondary hypogonadism, where 12.5 mg to 25 mg orally once daily was used.

Those studies explored treatment for up to six months, but long-term safety and efficacy were not established.

This is not a self-treatment medicine, and it should not be sourced from unregulated online sellers.

In UK practice, the important point is that clinicians would usually avoid guessing a dose in patients with other health problems.

Children were not studied at all, so there is no paediatric use.

There are also no established dose adjustments for older adults, liver disease, kidney disease, or other comorbidities.

That makes specialist review essential, because a safer licensed alternative may be more appropriate.

Regimen summary:

If a dose is missed, the advice from the source data is simple: take it as soon as remembered unless the next dose is close, and do not double up.

If too much is taken, there is no established antidote, so urgent medical help is needed for supportive care.

User Testimonials

People reading about Androxal often want to know what others have felt before they ask a clinician.

That is understandable, but there are no licensed UK patient experience datasets for enclomifene.

So the best that can be done is to summarise the kind of anecdotal comments that appear in discussion spaces such as Patient.info, fertility forums, and informal UK health communities.

Some people speak positively about the idea of supporting natural testosterone production rather than replacing testosterone directly.

Others focus on the hope that it may fit a fertility-preserving approach better than testosterone replacement therapy.

The problem is that online reviews can sound convincing even when the product is unregulated or not genuine.

What people report:

• Interest in testosterone support without direct testosterone replacement.
• Questions about fertility and hormone balance.
• Frustration about cost, authenticity, and availability.
• Concern about side effects and whether the tablets are genuine.

What the evidence actually shows:

• Androxal remains investigational and unapproved.
• There is no routine NHS prescribing pathway for it.
• Testimonials cannot replace blood tests or specialist review.
• Grey-market listings labelled as research chemical or enclomifene citrate may be misleading.

A useful rule is to treat online patient reviews as a starting point for questions, not as evidence that a medicine is safe, genuine, or effective.

Buying Guide

Androxal is not legitimately sold in UK pharmacies and is not available on an NHS prescription.

That means Boots, LloydsPharmacy, and Superdrug would not normally stock it as a licensed medicine.

Some online sellers may offer enclomifene as a research product, but those supplies are not regulated medicines and may be unsafe or counterfeit.

For UK patients, that distinction matters more than a headline price.

Prescription charges in England differ from Scotland, Wales, and Northern Ireland, where prescriptions are generally free, but that point is largely academic here because the medicine is not routinely prescribed.

Where legitimate treatment is needed, specialist clinics may consider licensed alternatives after assessment.

In our online pharmacy, androxal is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

That is a purchase-context service note, but it should never replace clinical judgement or a conversation about safer, licensed options.

Source comparison:

What Is Inside & How It Works

Patients usually want the plain-English version first: what is enclomifene, and what does it actually do?

Enclomifene is the INN, while enclomiphene is the US spelling used in some sources.

It is the active (E)-isomer of clomiphene and was intended as enclomifene citrate tablets, although no commercial packaging reached market because development was discontinued.

Pharmacologically, it is a nonsteroidal selective oestrogen receptor modulator, or SERM, and more specifically an oestrogen receptor antagonist used investigationally in men.

The simple way to think about it is this:

• It blocks the oestrogen signal at the hypothalamus.
• The brain responds by increasing LH and FSH.
• Those hormones may encourage the testes to produce more endogenous testosterone.

That is why it was explored in male hypogonadism and fertility-related contexts.

It is different from testosterone replacement therapy, which supplies testosterone directly.

It is also why people often compare it with clomifene or clomiphene citrate, because those medicines sit in a similar treatment family.

For patients, the key point is not receptor jargon; it is that the medicine was designed to stimulate the body’s own production rather than replace hormones from outside.

Main Indications

People often ask whether Androxal is approved for low testosterone, fertility, or both.

The short answer is that there are no MHRA-approved uses for Androxal and no UK licensed indication.

The only studied use in the supplied data is male secondary hypogonadism in clinical trials.

It was explored in men with symptoms linked to low testosterone, including fertility-related settings, but it was never authorised for sale in the US, EU, or any other regulated market.

In UK clinics, that means any discussion usually turns to licensed alternatives or specialist endocrine and fertility pathways instead.

Evidence and approval status:

The safest interpretation is that this is a studied medicine, not an approved NHS option.

Interaction Warnings

Because Androxal is not licensed, there is no robust UK interaction dataset in the way there is for established NHS medicines.

Even so, practical caution still matters.

There are no formal food interaction rules in the supplied data, but alcohol, high caffeine intake, and supplement use should be discussed with a pharmacist, especially if nausea or mood changes are present.

That is particularly sensible for patients who already use fertility supplements, gym products, or herbal blends.

Drug conflicts are also hard to map because there are no officially approved UK interaction charts for Androxal.

Still, caution makes sense with other hormone-related medicines, fertility treatments, and medicines that could affect clot risk or vision.

Safety checklist for interactions:

• Tell the pharmacist about all medicines, including supplements.
• Avoid combining it with unregulated products from online sources.
• Report any blurred vision or new spots straight away.
• Seek help if you feel unwell after taking something bought from a grey-market seller.

Any suspected adverse reaction can be reported via the MHRA Yellow Card scheme, even if the product was obtained outside standard pharmacy channels.

Latest Evidence & Insights

The evidence story for Androxal is simple, and not particularly flattering.

It remains experimental, with no approved UK or EU marketing authorisation and no routine NHS use.

Clinical trial work attracted interest because of the hormone pattern it could produce, but that has not turned into a licensed treatment pathway.

The European Medicines Agency refused marketing authorisation in 2018 for secondary hypogonadism, and the FDA did not approve it either.

That matters because newer discussion between 2022 and 2025 has not changed the basic regulatory picture.

Evidence snapshot:

Patients are better off relying on GP, endocrinology, or fertility specialist advice than on social media summaries.

Alternative Choices

When people cannot get Androxal, they usually want to know what the realistic UK alternatives are.

The main comparisons are clomiphene citrate, tamoxifen, and testosterone replacement therapy.

Clomiphene citrate is the better-known related medicine and has a similar mechanism, so clinicians are more familiar with it.

Tamoxifen is another SERM that may come up in specialist conversations.

TRT is different because it replaces testosterone directly rather than encouraging the body to make more of its own.

Which option may suit which goal?

• Fertility-preserving approach: A SERM-style option may be discussed in specialist care.
• Direct testosterone replacement: TRT may be used when hormone replacement is the main aim.
• Established UK prescribing path: Licensed alternatives are more realistic than Androxal.
• Monitoring need: Blood tests and symptom review matter whichever route is chosen.

The right choice depends on symptoms, blood results, fertility plans, and specialist review.

That is exactly why a medicine with no UK licence is not the place to start treatment decisions.

Regulation Snapshot

This is the section that clears up most of the confusion.

Androxal, or enclomifene, has no MHRA approval, no UK licence, and no ATC code.

That means it cannot be treated like a routine NHS medicine.

In UK prescribing practice, clinicians generally use licensed medicines, or they use an off-label option with specialist justification when appropriate.

Androxal does not currently fit either standard pathway.

People usually hear the name through forums, fertility discussions, or overseas sources rather than through a GP surgery.

Major chains and registered pharmacies should not sell it as a standard medicine.

Regulatory summary:

Grey-market or research chemical products sold online create the main safety risk, because authenticity and quality cannot be assumed.

Frequently Asked Questions

Is Androxal available on the NHS?

No.

It has no MHRA approval and no routine NHS prescribing route in the UK.

Can I buy it from Boots or online?

Not legitimately from UK pharmacy chains.

Boots, LloydsPharmacy, and Superdrug would not normally stock it as a licensed medicine, and online research listings are not the same as regulated pharmacy supply.

What is the difference between enclomifene and clomiphene citrate?

Enclomifene is the active (E)-isomer of clomiphene.

Clomiphene citrate is the better-known related medicine and is more established in clinical practice.

What should I do if I get side effects?

Speak to a pharmacist, GP, or NHS 111, especially if you notice blurred vision, spots, or any unusual reaction.

Any adverse effect can also be reported through the MHRA Yellow Card scheme.

Guidelines For Proper Use

The most important counselling point is simple: do not self-source Androxal from unregulated websites.

It is not approved in the UK, and products sold online may be counterfeit or unsafe.

If a clinician ever used it in a specialist setting, the usual practical advice would be to follow the prescribed routine carefully, keep the product in the original packaging, and check the patient leaflet.

Storage in the source data is straightforward: room temperature, 15 to 30°C, with protection from moisture.

For missed doses, the advice is to take the tablet when remembered unless the next one is near, and not to double up.

If too much is taken, there is no established antidote, so urgent help is needed.

Pharmacist-style support checklist:

• Take only prescribed medicines.
• Keep a symptom diary if side effects appear.
• Bring all supplements to the pharmacy review.
• Report visual changes quickly.
• Use NHS services for advice if anything feels wrong.

For support pathways, patients normally start with a community pharmacist, then their GP, and then a specialist referral if needed.

In England, prescription charges may apply to licensed alternatives, while prescriptions are typically free in Scotland, Wales, and Northern Ireland.

Delivery Across United Kingdom